Trends in the subsite and morphology of oesophageal and gastric cancer in England and Wales 1971-1998

Alimentary Pharmacology and Therapeutics

Volumn 17, Issue 5, 2003, Pages 665-676

  Newnham, A ^a,e   Quinn, M J ^b   Babb, P ^b   Kang, J Y ^c   Majeed, A ^d  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b OFFICE FOR NATIONAL STATISTICS   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

^e Thames Cancer Registry   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCULATION; CANCER INCIDENCE; CANCER REGISTRY; CARDIA; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROBABILITY; STANDARDIZATION; STOMACH ADENOCARCINOMA; STOMACH CARCINOMA; UNITED KINGDOM;

ADENOCARCINOMA; AGE DISTRIBUTION; CARCINOMA, SQUAMOUS CELL; CARDIA; ENGLAND; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MALE; STOMACH NEOPLASMS; WALES;

EID: 0037359379     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01521.x     Document Type: Article

References (24)

1. Coleman MP, Esteve J, Damiecki P, et al. Trends in Cancer Incidence and Mortality. IARC Scientific Publications No. 120. Lyons: International Agency for Research on Cancer. 1993.
2. Botterweck AAM, Schouten LJ, Volovics A, et al. Trends in the incidence of adenocarcinoma of the oesophagus and gastric cardia in ten European countries. Int J Epidemiol 2000; 29: 645-54.
3. Wayman J, Forman D, Griffin M. Monitoring the changing pattern of esophago-gastric cancer: data from a UK regional cancer registry. Cancer Causes Control 2001; 12: 943-9.
4. Newnham A, Quinn MJ, Babb P, et al. Trends in oesophageal and gastric cancer incidence, mortality and survival in England and Wales 1971-1998/1999. Aliment Pharmacol Ther 2003; in press.
5. Quinn M, Babb P, Brock A. et al. Cancer Trends in England and Wales 1950-1999. Series SMPS No. 66. London: Office for National Statistics, 2001.
6. Brewster DH, Fraser LA. McKinney PA, et al. Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland. Br J Cancer 2000; 83(3): 387-90.
7. Hansen S, Wiig JN, Giercksky KE, et al. Esophageal and gastric carcinoma in Norway 1958-1992: incidence time trend variability according to morphological subtypes and organ subsites. Int J Cancer 1997; 71: 340-4.
8. Wijnhoven BPL, Louwman MWJ. Tilanus HW, et al. Increased incidence of adenocarcinomas at the gastro-oesophageal junction in Dutch males since the 1990s. Eur J Gastroenterol Hepatol 2002; 14: 115-22.
9. Hansson L-E, Sparén P, Nyrén O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg 1993; 80: 374-7.
10. Hansson L-E, Sparén P, Nyrén O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993; 54: 402-7.
11. Levi F, Te V-C, Randimbison L, et al. Re: Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence [Letter]. J Natl Cancer Inst 1999; 91: 1585-6.
12. Zheng T, Mayne ST, Holford TR, et al. The time trend and age-period-cohort effects on incidence of adenocarcinoma of the stomach in Connecticut 1955-1989. Cancer 1993; 72: 330-40.
13. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
14. Ekström AM, Hansson L-E, Signorello LB, et al. Decreasing incidence of both major histologic subtypes of gastric adenocarcinoma - a population-based study in Sweden. Br J Cancer 2000; 83: 391-6.
15. Dolan K, Sutton R, Walker SJ, et al. New classification of oesophageal and gastric carcinomas derived from chain ging patterns in epidemiology. Br J Cancer 1999; 80: 834-42.
16. Banatvala N, Mayo K, Megraud F, et al. The cohort effect and Helicobacter pylori. J Infect Dis 1993; 168: 219-21.
17. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-53.
18. Lagergren J, Bergstrom R, Lindgren A. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340: 825-31.
19. Lagergren J, Bergstrom R, Nyren O. Association between body mass and adenocarcinoma of the oesophagus and gastric cardia. Ann Intern Med 1999; 130: 883-90.
20. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the oesophagus and gastric cardia. J Natl Cancer Inst 1998; 90: 150-5.
21. Brown LM, Swanson CA. Gridley G, et al. Adenocarcinoma of the esophagus: role of obesity and diet. J Natl Cancer Inst 1995; 87: 104-9.
22. Vaughan TL, Davis S, Kristal A, et al. Obesity, alcohol, and tobacco as risk factors for cancers of the oesophagus and gastric cardia: adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 1995; 4: 85-92.
23. Cheng KK, Sharp L, McKinney PA, et al. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 2000; 83: 127-32.
24. Department of Health. Table 6. Body mass index (BMI), by survey year, age and sex. Health Survey for England: Trend Data for Adults 1993-2000. Available from: URL: http://www.doh.gov.uk/stats/trends1.htm.